
The companies focus on fibrosis and oncology, and novel treatments for respiratory conditions, respectively

Influence rarely happens in a single post. Trust is built through repeated, credible interactions over time

This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments

As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?

The traditional model for gathering insights is reaching a breaking point. Healthcare Professionals (HCPs) are increasingly time-poor and difficult to reach. Simultaneously, the costs of traditional market research are rising,...

Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.

In addition, Bruno Rebelo is appointed to the NY office as Chief Creative Officer

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year's congress revealed for pharmaceutical organisations. Together, they...

Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.

The companies plan to research and develop 12 new cancer treatments

Starting out in 1986 as a team of two in Manchester’s Northern Quarter, Havas Lynx has much to celebrate, having grown to become an international healthcare communications agency with offices...

The treatment is currently being evaluated in a phase 1/2 multicentre clinical study